Beijing Yikangxing Pharmaceutical

Beijing Yikangxing Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and commercialization of both innovative drugs and high-end generic medications. The company maintains a strategic focus on therapeutic areas with high clinical demand, including oncology, cardiovascular health, and metabolic disorders. Yikangxing operates integrated R&D facilities that support the full drug development lifecycle from discovery through clinical trials to GMP-compliant manufacturing. The company is publicly traded on China's National Equities Exchange and Quotations (NEEQ), reflecting its established presence in the regional life sciences sector. Its portfolio includes several proprietary candidates in clinical development alongside a stable of marketed generic products.